top of page

Innovative Treatment for Anaplastic Astroblastoma Astrocytoma 间变性星形母细胞瘤/星形胶质母细胞瘤的创新治疗



treatment for anaplastic astroblastoma astrocytoma
Before ECCT

A resilient 36-year-old woman from Turkey, faced an arduous battle against anaplastic astroblastoma/astrocytoma. Her journey began in 2013 when she was diagnosed and underwent post-op radiotherapy, displaying incredible strength and determination.

这位36岁来自土耳其的坚韧女性,在面对患有间变性星形细胞瘤/星形胶质瘤的艰难斗争中展现了惊人的毅力。2013年确诊后接受手术后放疗,展现了令人难以置信的坚强和决心。

Despite her resilience, a relapse occurred in September 2020, leading her to undergo a second surgery followed by secondary-line radiotherapy.


treatment for anaplastic astroblastoma astrocytoma
After 3rd line Radiotherapy, Before ECCT

Undeterred by the setbacks, she embraced a treatment regimen consisting of Bevacizumab and Irinotecan, showcasing unwavering courage and hope in her fight against the condition.

尽管经历了艰难,2020年9月出现复发,随后进行了第二次手术并接受了二线放疗。她并没有被挫败,而是接受了贝伐珠单抗和伊立替康的治疗方案,展现出对病情斗争的坚定勇气和希望。
treatment for anaplastic astroblastoma astrocytoma
2 months of ECCT + Bevacizumab + Irinotecan

In February 2022, she commenced an innovative treatment for anaplastic astroblastoma astrocytoma ECCT regimen, committing to five sessions per week, with each session lasting 15-120 seconds. Remarkably, after two months of this combined treatment alongside Bevacizumab and Irinotecan, the patient exhibited a commendable response. Notably, signs of progression halted, and her condition stabilized, offering a glimmer of hope in her ongoing battle.

2022年2月,她开始了一项ECCT疗程,每周进行五次疗程,每次持续15-120秒。令人瞩目的是,在与贝伐珠单抗和伊立替康联合治疗两个月后,患者展现出了令人钦佩的反应。值得注意的是,病情没有继续恶化,而是稳定下来,为她的持续抗争带来了一丝希望。
treatment for anaplastic astroblastoma astrocytoma
After 5 months of ECCT + Bevacizumab + Irinotecan

After a strenuous 11-month period of various treatments, including chemotherapy and radiotherapy, her perseverance paid off. The positive impact on her survival was evident, and the most encouraging sign was her regaining the ability to walk, a monumental achievement after months of enduring the combination treatments.

在经历了长达11个月的各种治疗,包括化疗和放疗后,她的坚韧不拔取得了回报。患者的生存状况得到了积极的影响,最令人鼓舞的迹象是,她重新恢复了行走的能力,在经历了数月的联合治疗后取得了巨大的成就。

treatment for anaplastic astroblastoma astrocytoma
After 11 months of ECCT

Through her resilience, endurance, and the collaborative efforts of her medical team, she has not only shown remarkable progress but has also become a beacon of inspiration for those facing similar challenges. Her journey is a testament to the power of perseverance, hope, and the advancements in medical science, offering optimism and courage to others in similar circumstances.

通过她的坚韧、持久以及医疗团队的合作努力,她不仅展现出了显著的进步,还成为了面对类似挑战的人们的鼓舞力量。她的经历证明了坚韧、希望以及医学科学的进步的力量,为其他面临类似困境的人们带来了乐观和勇气。

bottom of page